Bimagrumab Explained: The Muscle-Preserving Weight Loss Drug Rochester Patients Are Asking About
One of the biggest concerns with today’s weight loss medications is muscle loss. When people lose weight quickly, some of that loss comes from lean tissue, not just fat. Bimagrumab is an investigational drug designed to address exactly that problem. This guide offers bimagrumab explained in plain language. It covers how it works, what its trials found, and what it means for Rochester patients.
At Vital Health Medical Care in Pittsford, Dr. Sanin Syed, MD, focuses on helping patients lose fat while protecting muscle. She is dual board-certified in obesity medicine and internal medicine, with more than 20 years in medicine. Bimagrumab is not available today. Still, the science behind it offers useful lessons for anyone on a weight loss medication now.
Quick Answer: What Is Bimagrumab?
Bimagrumab is an investigational antibody, now owned by Eli Lilly, that blocks signals in the body that limit muscle growth. As a result, it can reduce fat while preserving or even increasing muscle. In a phase 2 trial, combining bimagrumab with semaglutide produced about 22% weight loss at 72 weeks. More importantly, most of that loss came from fat.
- How it works: blocks activin type II receptors, which normally restrain muscle growth
- Main benefit: shifts weight loss toward fat and away from muscle
- Key trial: BELIEVE, published in Nature Medicine in March 2026
- How it was given: by intravenous infusion in trials
- Status: phase 2; not FDA-approved and not available in Rochester
Bimagrumab Explained: Key Facts at a Glance
The table below summarizes bimagrumab’s status and evidence as of November 2026. Most results come from phase 2 trials, which are not yet confirmed in larger studies.
|
Feature |
Bimagrumab |
| Drug type | Monoclonal antibody that blocks activin type II receptors |
| Developer | Eli Lilly, after acquiring Versanis Bio in 2023 |
| How it is given | Intravenous infusion in trials; other forms under study |
| Key obesity trial | BELIEVE: about 22.1% weight loss at 72 weeks with semaglutide |
| Body composition finding | Most weight lost with the combination came from fat |
| Most common side effects | Muscle spasms or cramps, diarrhea, and acne |
| FDA status | Not approved; phase 2 as of November 2026 |
Why Muscle Loss Matters During Weight Loss
Whenever people lose weight, some of the loss usually comes from lean mass. Lean mass includes muscle, organs, water, and connective tissue. In large trials of GLP-1 medications, lean mass made up roughly one-quarter to two-fifths of total weight lost.
Unfortunately, losing too much muscle can affect strength, balance, and long-term weight maintenance. This concern is greater for older adults and people with low muscle mass to begin with. In addition, muscle contributes to the energy your body uses at rest. Preserving it may help you keep weight off after treatment. That is why researchers are interested in drugs that shift weight loss toward fat.
How Bimagrumab Works
Normally, the body has natural signals that limit how much muscle it builds. Proteins such as myostatin and activin send these signals through activin type II receptors. Bimagrumab is an antibody that blocks those receptors.
As a result, the signals that restrain muscle growth are turned down. In studies, this led to more lean mass and less fat. That combination is rare among weight loss treatments, which usually reduce both. Researchers believe bimagrumab may also act directly on fat tissue, which could explain some of its fat-reducing effects.
However, bimagrumab does not work like GLP-1 medications. It does not mainly reduce appetite. For that reason, it has been studied mostly in combination with appetite-reducing drugs such as semaglutide and tirzepatide.
What the Clinical Trials Found
Earlier Trial in Type 2 Diabetes
A 48-week phase 2 trial, published in 2021, studied bimagrumab alone in adults with obesity and type 2 diabetes. Overall, participants lost substantial fat mass, including visceral fat and liver fat. At the same time, their lean mass increased. Their A1C also improved compared with placebo.
The BELIEVE Trial With Semaglutide
So far, BELIEVE is the most important bimagrumab trial. It randomized 507 adults with obesity or overweight, without diabetes. Participants received intravenous bimagrumab, semaglutide, both, or placebo. Results were published in Nature Medicine on March 2, 2026.
At 48 weeks, the highest-dose combination reduced total body fat mass by about 42%. By comparison, semaglutide alone reduced fat mass by about 25%, according to published summaries. At 72 weeks, the combination produced about 22.1% weight loss. Meanwhile, semaglutide alone produced about 15.7%.
Above all, the body composition results stood out. With the combination, roughly 93% of weight lost came from fat, according to a summary from Pennington Biomedical Research Center. With semaglutide alone, the share was about 72%. However, the 72-week analyses were post hoc, which means they need confirmation in larger trials.
Trials With Tirzepatide
Meanwhile, Lilly has also tested bimagrumab with tirzepatide, the active ingredient in Zepbound. In September 2025, Lilly ended one of these phase 2 trials, citing strategic business reasons. Another phase 2 trial of the combination continued, with enrollment complete as of 2026. Results had not been widely reported as of November 2026.
Side Effects and Safety
Notably, bimagrumab has a different side effect profile from GLP-1 medications. In BELIEVE, the most common side effects included muscle spasms or cramps, diarrhea, and acne. Muscle spasms were reported by a majority of people taking bimagrumab in some groups.
In addition, the trial noted changes in some blood lipid levels and early laboratory abnormalities. The study’s authors suggested that the high intravenous loading doses may have contributed. They also noted that a subcutaneous form, injected under the skin, might reduce these effects. Long-term safety remains under study.
When Could Bimagrumab Be Available?
No approval date has been announced. As of August 2026, no phase 3 bimagrumab obesity trial was publicly listed, and no regulatory filing had been identified. Phase 3 trials typically take several years. As a result, bimagrumab is unlikely to reach US pharmacies before the end of the decade. Approval is also not guaranteed.
Why You Should Not Buy Bimagrumab Online
Unfortunately, some websites sell products labeled as bimagrumab or other “muscle-preserving” compounds. Bimagrumab is a complex antibody made through specialized manufacturing, so legitimate copies are extremely unlikely. These products are not FDA-approved, and their contents and safety are not verified.
Similarly, the same caution applies to selective androgen receptor modulators, or SARMs, which are often marketed for muscle building. The FDA has warned consumers about SARMs in bodybuilding products. If you want access to an investigational drug, the only safe route is a registered clinical trial.
Other Muscle-Focused Approaches in Development
Bimagrumab is not the only drug aiming to protect muscle during weight loss. Several companies are testing other antibodies that block myostatin or related signals, usually alongside GLP-1 medications. Most of these programs are in early or mid-stage trials. Therefore, it will likely be several years before any muscle-preserving drug is approved for weight loss.
In the meantime, these studies all point to the same message. The quality of weight loss matters, and preserving muscle can support strength, function, and long-term results. That message is already shaping how physicians plan nutrition, exercise, and medication today.
How to Protect Muscle Today
Bimagrumab is not available, but proven strategies can help protect muscle right now. Most of them are already part of a well-designed medical weight loss program. These include the following:
- Resistance training: regular strength exercise gives muscle a reason to stay
- Adequate protein: spread across meals, with targets set by your care team
- A steady pace: gradual dose increases help you keep eating enough
- Body composition tracking: confirms that weight loss is coming mainly from fat
- Sleep and recovery: muscle repair happens during rest
In fact, the BELIEVE trial reinforces the value of these steps. It shows that the composition of weight loss matters, not just the number on the scale.
Questions to Ask Your Doctor About Muscle and Weight Loss
If bimagrumab has caught your interest, these questions can help guide your next visit:
- How much of my weight loss so far has come from fat versus lean mass?
- Is my protein intake enough to support my muscle?
- What kind of strength training would be safe and effective for me?
- Am I at higher risk of muscle loss because of my age or health?
- Are there clinical trials for muscle-preserving drugs I might qualify for?
What We See in Practice
Often, patients ask about bimagrumab after reading about muscle loss on GLP-1 medications. In our experience, the concern is valid, but much of it can be addressed today. Patients who combine strength training, adequate protein, and regular body composition scans tend to protect muscle better. Seeing their numbers on a scan also helps them adjust early. For most, the practical answer is a stronger plan now, not waiting for a new drug.
How Vital Health Medical Care Can Help
Vital Health Medical Care builds muscle protection into every weight loss plan. Each plan starts with a comprehensive consultation and a body composition scan. Dr. Syed then builds a plan that may include FDA-approved medication, nutrition counseling, culinary medicine, exercise planning, and behavioral coaching.
Then, regular follow-up scans help confirm that weight loss is coming mainly from fat. If lean mass drops faster than expected, the plan can be adjusted early. If bimagrumab or another muscle-preserving drug becomes FDA-approved, the team can help you decide whether it fits your plan. Patients come from across the Rochester area, including Brighton, Penfield, Fairport, Webster, and Henrietta.
Frequently Asked Questions
What is bimagrumab?
Bimagrumab is an investigational antibody that blocks activin type II receptors, which normally restrain muscle growth. Eli Lilly is developing it for obesity, mainly in combination with GLP-1 medications. It is not FDA-approved.
Does bimagrumab prevent muscle loss?
In trials, it helped shift weight loss toward fat. In the BELIEVE trial, roughly 93% of weight lost with the bimagrumab and semaglutide combination came from fat. These results still need confirmation in larger trials.
How much weight do people lose with bimagrumab?
During BELIEVE, the high-dose combination of bimagrumab and semaglutide produced about 22.1% weight loss at 72 weeks. Semaglutide alone produced about 15.7%. Bimagrumab alone produced smaller weight loss but improved body composition.
What are the side effects of bimagrumab?
The most common side effects in trials were muscle spasms or cramps, diarrhea, and acne. Some lipid and laboratory changes were also reported. Long-term safety is still being studied.
Is bimagrumab FDA-approved?
No. As of November 2026, bimagrumab is in phase 2 trials. No phase 3 obesity trial or FDA filing had been publicly announced.
Can I get bimagrumab in Rochester?
No, not outside of a clinical trial. Products sold online as bimagrumab are not FDA-approved and are unlikely to be genuine. The only safe access is through a registered clinical trial.
How can I protect muscle while taking Wegovy or Zepbound?
Regular strength training, adequate protein, and a gradual dose increase are the most effective strategies today. Body composition tracking helps confirm that weight loss is coming mainly from fat.
Do I need a referral to see a weight loss doctor in Rochester?
No referral is needed at Vital Health Medical Care. You can call 585-662-5786 to schedule a consultation directly. The team will also help verify your insurance benefits before treatment begins.
Better Weight Loss, Not Just More
Bimagrumab represents an important shift in obesity research. The focus is moving from how much weight people lose to what kind. Its phase 2 results are striking, but larger trials must still confirm them. With bimagrumab explained, the key lesson is clear: protecting muscle matters, and you can start today. A plan that combines medication, protein, strength training, and body composition tracking puts that lesson into practice.
If you want help protecting muscle while you lose weight, Dr. Sanin Syed and her team at Vital Health Medical Care can help.
Meet Dr. Sanin Syed – Leading Medical Weight Loss Specialist in Rochester, NY
Dr. Sanin Syed, founder and CEO of Vital Health Medical Care, is a board-certified obesity and internal medicine specialist. With over two decades of experience, Dr. Syed is dedicated to helping her patients achieve lasting weight loss and a healthier lifestyle.
- Recognized Expertise: Dr. Syed’s knowledge has been featured on NPR’s Evan Dawson Show and in the Rochester Academy of Medicine.
- Commitment to Patient Health: She focuses on building sustainable health habits and lifestyle changes that support long-term success.
Our clinic, located at 10 Office Parkway, Suite 100, Pittsford, NY, provides a welcoming and professional setting for patients who are ready to make positive changes.
Why Choose Vital Health Medical Care?
Experienced Weight Loss Doctor
Dr. Sanin Syed is one of the leading weight loss doctors in New York, with over 20 years of experience in medicine and obesity management. She holds dual board certifications from the American Board of Obesity Medicine and the American Board of Internal Medicine, ensuring you receive the highest standard of care.
Personalized Care
At Vital Health Medical Care, we believe in a personalized approach to weight loss. Our programs are tailored to meet your unique needs, ensuring you receive the best possible care and support on your weight loss journey.
Comprehensive Support
We provide ongoing support throughout your weight loss journey, including regular monitoring and adjustments to your plan as needed. Our comprehensive approach ensures you have the resources and guidance necessary to achieve your weight loss goals.
Insurance Acceptance
We understand that managing healthcare costs is important. That’s why we accept a wide range of insurance plans to make our weight loss treatments accessible and affordable for everyone.
Nutritional Counseling
Our qualified nutritionists create personalized diet plans that fit your lifestyle and dietary preferences. We provide expert guidance on making healthy food choices that support your weight loss goals.
Physician Consultation
Our experienced physicians, led by Dr. Syed, will work with you to find the best medication and treatment plan for your needs. We utilize FDA-approved medications such as Wegovy and Zepbound to support your weight loss efforts.
Health Coaching
Our health coaches provide ongoing support and motivation, helping you stay on track with your weight loss goals. They offer practical advice and encouragement to help you overcome challenges and achieve lasting success.
Culinary Medicine
Learn how to prepare healthy, delicious meals that support your weight loss journey with guidance from our culinary medicine experts. We offer cooking classes and workshops to help you develop the skills needed to maintain a healthy diet.
Meal Replacement
We offer meal replacement options that are nutritious and convenient, helping you manage your calorie intake effectively. Our meal replacements are designed to support your weight loss goals while ensuring you receive essential nutrients.
Individualized Exercise Plan
Our fitness experts develop personalized exercise plans tailored to your fitness level and goals. We provide guidance on the best types of exercise for weight loss and overall health, ensuring you achieve optimal results.
Comprehensive Weight Loss Treatment in Rochester, New York
Vital Health Medical Care offers evidence-based weight loss treatments designed to help you succeed. We take a holistic approach, integrating medication, diet, exercise, and behavioral changes to ensure long-term success. Contact us today to schedule a consultation and start your journey.


